|
I.
Philosophy
Two of the objectives of the American Society of Consultant Pharmacists Foundation are (1) to design, conduct, coordinate, and fund educational programs and initiatives that enhance appropriate, effective, and safe medication use in the senior population; and (2) to develop, support, and promote the patient-centered principles and practice of senior care pharmacy.
Accordingly, the ASCP Foundation conducts a post-graduate traineeship in Parkinson's disease pharmacotherapy. The traineeship offers unique opportunities for pharmacists to learn new skills, sharpen existing skills, and render new services.
The Parkinson's Disease Pharmacotherapy Traineeship will be conducted at the Parkinson's Disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. The preceptor is Tanya Simuni, MD, Medical Director, Parkinson's Disease and Movement Disorders Center and Associate Professor of Neurology, Northwestern University Feinberg School of Medicine.
The Parkinson's Disease Pharmacotherapy Traineeship is administered by the ASCP Foundation, 1321 Duke Street, Alexandria, Virginia 22314. The August 2012 session is funded by an educational grant from UCB.
II.
Objectives
The primary objectives of the ASCP Foundation Parkinson's Disease Pharmacotherapy Traineeship are to prepare pharmacists to provide a high level of pharmaceutical care to persons with Parkinson's disease and other neurologic disorders; to create pharmacist advocates for appropriate care and treatment of persons with Parkinson’s disease in the settings where they practice; and to positively impact the way pharmacists perceive their role in the care and treatment of persons with Parkinson’s disease and other movement disorders.
The full-time, five-day (Monday through Friday) traineeship will provide individualized, intensive, experiential training for selected practicing pharmacists. Participants should expect immersion into a busy, academic-based movement disorders clinic where they will participate in patient visits and have one-on-one interactions with physicians, patients and families. The traineeship offers the trainee an opportunity to observe and participate in the development of treatment plans for persons with Parkinson’s disease and other movement disorders, including alternative clinical diagnoses, control of medication adverse effects, drug interactions, dementia and depression, adjustment of therapy, and the use of adjunctive medications. The traineeship also offers the opportunity for pharmacists to work with an interdisciplinary team consisting of physicians, nurses, social worker, speech and physical therapists, caregivers, family members, and patients to positively impact the treatment outcome.
Upon successful completion of the Parkinson’s Disease
Pharmacotherapy Traineeship, the pharmacist will be able to:
- Discuss the pathophysiology and differential diagnosis of Parkinson’s
disease and other movement disorders and the relation to treatment strategies.
- Discuss protective or preventive treatment, symptomatic treatment, and restorative or regenerative treatment for Parkinson's disease.
- Describe possible therapeutic management strategies
for persons with early, moderate, and advanced Parkinson’s disease.
- Identify and recommend therapies for management of non-motor manifestations of Parkinson's disease.
- Identify and recommend therapies for management of problems frequently encountered with long-term treatment of Parkinson's disease.
- Identify and discuss
patient counseling issues concerning Parkinson’s disease
therapy.
- Assess non-motor disability in patients with Parkinson’s disease.
- Assess the effect of drug management changes on Parkinson's disease symptoms.
- Describe research studies and novel treatment options to improve the control of Parkinson's disease symptoms.
III.
Qualifications of the Traineeship Applicant
- The applicant will be a graduate of a school or college
of pharmacy accredited by the Accreditation Council for Pharmacy Education or the Canadian Council for Accreditation of Pharmacy Programs. NOTE: Applicants from outside
the United
States and Canada should contact the ASCP Foundation
regarding this qualification.
- The applicant will actively practice pharmacy and have at least two years experience in pharmacy practice or comparable qualifications.
- The applicant will demonstrate strong
clinical knowledge and skills by citing clinical practice
experience.
- The applicant will have a demonstrated interest
in
the pharmacotherapy and overall treatment of Parkinson’s
disease.
- The applicant will be affiliated with health care facilities
or organizations able and willing to implement the results
of the
traineeship experience.
IV.
Application Procedure
-
The applicant must submit the completed application form
and the exhibits listed in item 2 below.
- The
following items are to be appended to
the application form, each clearly labeled
in the upper right-hand
corner, as indicated (Exhibit A, Exhibit B, Exhibit C):
Exhibit A. Curriculum vitae, which
must include the applicant’s
education, experience record in pharmacy practice (in
reverse chronological order, most recent first), and
any relevant publications,
presentations, and community service.
Exhibit B. A statement of not more
than three typed, double-spaced pages describing:
- Why the applicant wants to participate in the
traineeship and the applicant’s expectations of the traineeship
experience
- Nature and extent of professional or personal
involvement with persons with Parkinson’s disease and
other neurological disorders, caregivers, or family members
- Current level of clinical services provided by the applicant,
including total number of patients served, geographic distribution
(urban, rural, suburban), ethnic distribution (Black, White,
Hispanic, Asian/Pacific Islander, American Indian/Eskimo/Aleut),
and number of patients with Parkinson’s disease
- Special services or programs provided by the applicant
- How the traineeship will enhance the pharmacy services
currently provided
- How the results of the traineeship
experience will be incorporated into the applicant’s
practice.
Exhibit C*. A letter from the applicant’s
employer confirming support for the applicant’s
participation in the traineeship and willingness to implement
the results of the traineeship
experience. The letter should be addressed to the applicant
and signed by the chief executive officer, director of
pharmacy, clinical coordinator, or other appropriate
manager / supervisor in the organization.
*If the applicant is self-employed, this exhibit may be
omitted.
V.
Selection Procedure
- Applications
will be reviewed and ranked by a selection panel appointed
by the ASCP Foundation. Decisions of the
selection panel will be final and without appeal.
- Selection will be based solely on information submitted
to the ASCP Foundation by the traineeship applicant.
- The
ASCP Foundation will notify all traineeship applicants
of
the outcome of their applications.
VI. Conduct and Administration of the Traineeship
- The ASCP Foundation is the administrator of the
traineeship.
- The traineeship is awarded to an individual applicant.
- The trainee is responsible for expenses related to travel to the traineeship site, hotel, meals, and incidentals.
- The trainee may be required to sign a waiver of liability appropriate
to the specific training sites.
- The trainee will be required
to participate in all sessions of the activity, complete an evaluation,
and submit two case consults (see section VII, item 1,
below).
VII. Requirements of the Trainee
In order to ensure the traineeship participants use
the skills and knowledge gained in some measurable way, the following
post-traineeship requirements must be met:
- Traineeship participants are expected to write up and submit to the
ASCP Foundation two case consults for which they made recommendations
for treatment or interventions to improve care of patients with Parkinson’s
disease. The case consults will include:
- Description of the problem
- Ttreatment / intervention recommended and why
- Goals of treatment / intervention
plan
- How staff, caregivers, family members, and patients were involved
in treatment decisions and monitoring
- Expected outcomes
- How
outcomes were measured
- Actual outcomes and how and why they
differed from
the expected outcomes.
The format for the case consults will be distributed
after the traineeship.
- Traineeship participants are expected to become involved with their
local Parkinson’s disease support group by volunteering to speak
at meetings, write articles for newsletters, or participate in other ways
to meet a specific
need within their community.
- Traineeship participants will have the opportunity to participate in
the ASCP Foundation Traineeship Network by attending meetings and educational
programs at the ASCP Spring Conference and Annual Meeting, and by subscribing
to the Foundation’s Traineeship Network Email List Serv. Traineeship
participants may be asked to participate in educational programs at ASCP
meetings and assist the ASCP Foundation in promoting the traineeship.
VIII. Continuing Education
Trainees will earn 3.45 CEUs (34.5 contact hours) for successful completion of the Parkinson's Disease Pharmacotherapy Traineeship, a Practice-based Continuing Pharmacy Education activity. To receive continuing education credit, trainees must participate in all sessions of the activity, complete an evaluation at the conclusion of the traineeship and submit two case consults. Instructions for obtaining statements of continuing education credit will be provided to trainees within one month after successful completion of the activity and receipt of the evaluation and case consults.
 ® |
The
American Society of Consultant Pharmacists is accredited by
the Accreditation Council for Pharmacy Education as a provider
of continuing pharmacy education. This is activity number 0203-0000-12-030-L01-P. |
ASCP Foundation
The ASCP Foundation is the research and education affiliate of the American Society of Consultant Pharmacists. The mission of the ASCP Foundation is to improve the health and well-being of older persons through appropriate, effective, and safe medication use. The ASCP Foundation provides leadership, innovation, and expertise in medicines and aging to seniors and those who care for them. The unique focus of the ASCP Foundation is the development, integration, and application of knowledge regarding medication use in the senior population and the practice of senior care pharmacy to optimize health care outcomes.
|
